Abstract: Disposable wipes comprising of warming lubricants, glycerol and capsaicin, vitamin E oil, essential oils, Lavender and Lemon, and propyl paraben. The fragrance free disposable wipes comprises of 85% purified water, 0.4.% glycerol, 0.1% capsaicin, 0.9% vitamin E oil, and 0.1% propyl paraben. The disposable wipes with fragrance comprises of 80% purified water, 0.4.% glycerol, 0.1% capsaicin, 0.9% vitamin E oil, 0.5% of either the essential oils, Lavender or Lemon, and 0.1% propyl paraben. The warming effect is achieved by having one or more additives in the lubricant which are either always active or activated by your body.
Abstract: Compositions comprising thermo-modified nutshells, for example hazelnut shells, are described herein. The compositions can also comprise one or more feed additives, pharmaceutically acceptable diluents and/or excipients. Also included are methods for producing the thermo-modified nutshell compositions, and methods for using the compositions to treat diarrhea and adsorb toxins as well as promote growth and improve the overall health in humans and other animals.
Abstract: Compositions comprising at least one ingredient that stimulates, enhances, or increases CGRP expression, and a physiologically- or cosmetically-acceptable vehicle. The ingredient may be a compound, natural ingredient, such as a plant or fungus, derivatives, analogs, mimetics, synthetics and the like that stimulates CGRP expression. The CGRP plant includes plants, plant materials, plant extracts, synthetics, or combinations thereof that stimulate CGRP expression. The disclosure is also directed to methods of using the CGRP compositions for decreasing, reducing, or inhibiting fine lines or wrinkled skin.
Abstract: Disclosed is a method for preventing, improving and/or treating cornea damage or a corneal disease, including administering an effective amount of an extract of a persimmon tree for preventing, improving or treating cornea damage to a subject in need thereof. The extract may be a persimmon leaf extract and the extract is effective in suppressing inflammation of the cornea and protecting corneal cells.
Type:
Grant
Filed:
April 19, 2016
Date of Patent:
June 20, 2017
Assignee:
Korea Institute of Science and Technology
Inventors:
Sang Hoon Jung, Kyung A Kim, Suk-Woo Kang, Joo Young Lee, Hong Ryul Ahn, Youngwoo Song
Abstract: A composition useful for maintaining healthy levels of testosterone in men and women. The composition includes essential oils from a tree of the genus Picea or a product of this oil. The essential oil product can specifically come from essential oil from the plant Picea pungens, commonly referred to as Blue Spruce. Also disclosed is a method for maintaining healthy levels of testosterone in men and women utilizing the composition. In some implementations, the composition is a pharmaceutical composition that further includes a penetration enhancer. A method for utilizing the pharmaceutical composition for treating hypogonadism is also disclosed.
Abstract: The invention provides a composition for the prevention and inhibition of oxidative stress and hemolysis in human red blood cell wherein said composition compounds obtained from the aqueous stream of palm oil milling (palm oil vegetation liquor), in particular from vegetative liquor from the milling of palm oil fruit.
Type:
Grant
Filed:
January 17, 2014
Date of Patent:
June 6, 2017
Assignee:
MALAYSIAN PALM OIL BOARD
Inventors:
Nagendran Balasundram, Ravigadevi Sambanthamurthi, Yew Ai Tan, Kalyana Sundram, Mohd Basri Wahid, Samir Samman, Nihal S. Agar
Abstract: A dietary supplement composition is formulated in a therapeutic amount to treat and alleviate symptoms of hot flashes in a female subject, such as experiencing symptoms of perimenopause. The composition includes a phytoestrogen and lycopene in an oral dosage form. The phytoestrogen may include a plant lignan including at least one of Matairesinol, 7-hydroxymatairesinol, Secoisolariciresinol, Lariciresinol and Pinoresinol. The lycopene may include a lycopene complex having at least one of phytoene, phytofluene, beta-carotene, tocopherols and phytosterols.
Type:
Grant
Filed:
July 28, 2015
Date of Patent:
June 6, 2017
Assignee:
U.S. NUTRACEUTICALS, LLC
Inventors:
John A. Minatelli, W. Stephen Hill, Rudi E. Moerck, Jessica Engle
Abstract: Provided is a 15-PGDH activity adjusting function of a Dendropanax morbifera extract. More specifically, since it has been confirmed that the Dendropanax morbifera extract has an outstanding effect in suppressing 15-PGDH activity and so increasing PGE2, a composition of the present invention which contains the Dendropanax morbifera extract as an active ingredient has the advantage of being able to be used for producing a functional health food and a therapeutic agent for a disease associated with PGE2.
Type:
Grant
Filed:
November 28, 2014
Date of Patent:
May 16, 2017
Assignee:
Industry-Academic Coorperation Foundation, Chosun University
Abstract: The present invention relates to a composition comprising oil palm phenolics for use in providing neuroprotective effects and improving cognitive and motor functions abilities.
Type:
Grant
Filed:
January 29, 2010
Date of Patent:
May 9, 2017
Assignee:
MALAYSIAN PALM OIL BOARD
Inventors:
Ravigadevi Sambanthamurthi, Soon-Sen Leow, Yew Ai Tan, Kalyana Sundram P. Manickam, Mohd Basri Wahid
Abstract: The present invention belongs to a pharmaceutical composition preparation field of traditional Chinese medicine, and more particularly relates to a pharmaceutical composition for treating AIDS and preparation method thereof. The pharmaceutical composition of the present invention for treating AIDS comprises the following raw medicinal materials: Cordyceps Sinensis in an amount of 3-6 parts by weight, Dried Radix Rehmanniae in an amount of 4-12 parts by weight, Mylabris in an amount of 1-3 parts by weight, and Rhizoma Anemarrhenae in an amount of 3-6 parts by weight. The clinical trials show that the pharmaceutical composition has a relatively good therapeutic effect for treating AIDS.
Abstract: The present disclosure relates to a composition of an extract of fruits of Emblica officinalis selected from the group consisting of liquid juice of fruits of Emblica officinalis, a powder of an alcoholic extract of fruits of Emblica officinalis, a powder of a hydro alcoholic extract of fruits of Emblica officinalis, a powder of a water extract of fruits of Emblica officinalis, a powder of a juice of fruits of Emblica officinalis, a powder of dried fruits of Emblica officinalis, a powder of a water extract of dried fruits of Emblica officinalis, a powder of a pectinase treated water extract of fruits of Emblica officinalis, and combinations thereof; a method of preparing such compositions of extract of fruits of Emblica officinalis, more particularly which has application as a nutraceutical or pharmaceutical for increasing HDL-C levels in patients with memory loss and dementia especially in patients with neurodegenerative diseases like Alzheimer's disease and for the treatment of memory loss especially in Alz
Abstract: The invention relates to a plant extract combination of ginkgo and ginseng which is effective especially in a (synergistic) over-additive manner and optionally comprises whitethorn extract. Ginseng is used in the form of an ethanol/ethanol/water extract while ginkgo is used in the form of an acetone/acetone-water extract, for example, and the active extracts are prepared at specific quantitative ratios, particularly <1.1:1, thus unexpectedly boosting the prevention or also the treatment of a decline in the mental capacity related to age or also other disorders.
Abstract: Provided herein are methods of using therapeutically effective compositions of sandalwood oil to treat, prevent or reduce the recurrence of Clostridium infections.
Type:
Grant
Filed:
January 23, 2013
Date of Patent:
February 28, 2017
Assignee:
Santalis Pharmaceuticals, Inc.
Inventors:
Ian Clements, Paul Castella, Corey Levenson
Abstract: Compositions and methods for maintaining healthy skin and alleviating skin conditions such as redness, inflammation, irritation and skin aging, as well as for maintaining healthy scalp and hair are disclosed. The oral compositions disclosed comprise antioxidants including lycopene, gallic acid and ascorbic acid. Preferably lycopene has been water-extracted, more preferably under acid conditions. In the method of treatment aspect of the invention, an oral composition containing antioxidant(s) is administered to a person concurrently with a topical treatment for said skin conditions. Preferred topical compositions comprise cyclohexane polyols, such as cyclohexanediol or cyclohexanetriol.
Abstract: A method for treating, preventing or ameliorating breast cancer is provided by administering a synergistic amount of digitoxin and either actein or an extract of black cohosh comprising triterpene glycosides, and optionally another chemopreventive agent which may be paclitaxel. Methods for treating or preventing a neoplasia using a synergistic combination, and compositions of a synergistic combination of a cardiac glycoside and either actein or an extract of black cohosh comprising triterpene glycosides, and optionally another chemopreventive agent which may be a taxane are also provided. The compositions may also be used in a method for modulating Na+K+ATPase activity. In addition, a method for inhibiting the progression or development of breast cancer in vivo by administering either actein or an extract of black cohosh comprising triterpene glycosides and optionally at least one other chemoprotective agent is provided.
Type:
Grant
Filed:
December 30, 2011
Date of Patent:
February 7, 2017
Assignee:
RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK
Abstract: A supplement including a blend of turmeric, quercetin and rosemary, or holy basil, wasabi, and broccoli seed extract which are present in a balanced and predetermined ratio, and which stimulate the Antioxidant Response Element (ARE), Quinone Reductase, and/or induce related gene expression, for example, heme oxygenase-1 (HMOX-1) expression. The blend of ingredients can be formed as or in a dietary supplement adapted for administration to a subject. The dietary supplement can be formulated so that the turmeric, quercetin and rosemary are present in a predetermined ratio of 1:3:5, or holy basil, wasabi, and broccoli seed extract in a predetermined ratio of 1:1:0.2. Additional ingredients can be included in the supplement. The supplement can synergistically affect natural antioxidant response pathways within cells of a subject to whom the supplement is administered. A related method of use is also provided.
Type:
Grant
Filed:
November 25, 2013
Date of Patent:
December 13, 2016
Assignee:
Access Business Group International LLC
Inventors:
David J. Fast, Jennifer Patterson, Arun Rajgopal, Donald J. Pusateri, Kevin W. Gellenbeck, Jeffrey Scholten, Steven R. Missler, Russell K. Randolph, Jennifer Chuang, Yumei Lin, Valiantsina Kazlova
Abstract: The present invention relates to a process for preparing a sapucainha oil butter which enables obtaining an improved product for use in cosmetic compositions instead of silicone and fatty esters compounds.
Type:
Grant
Filed:
June 10, 2008
Date of Patent:
November 15, 2016
Assignee:
Natura Cosmeticos S.A.
Inventors:
Amanda Fernandes de Oliveira, Roberta Roesler, José Renato Cagnon, Débora Cristina Castellani
Abstract: The present invention relates to a pharmaceutical composition for preventing and treating cancer which comprises the extracts of Artocarpus altilis fruits, leaves, or stems, or the fractions thereof as active ingredients. The extracts of Artocarpus altilis fruits, leaves, or stems, or the fractions thereof, according to the present invention, suppress the activity of signal transducer and activator of transcription3 (STAT3) which plays an important role in the growth of a cancer cell line and in the immune function of the human body, and can thus be effectively used in the prevention and treatment of cancers such as colorectal cancer, stomach cancer, prostate cancer, breast cancer, renal cancer, liver cancer, brain tumor, lung cancer, uterine cancer, colorectal cancer, bladder cancer, or pancreatic cancer.
Type:
Grant
Filed:
July 26, 2013
Date of Patent:
November 8, 2016
Assignee:
Korea Research Institute of Bioscience and Biotechnology
Inventors:
Byoung-Mog Kwon, Dong Cho Han, Joongku Lee, Yoon-jeong Jeon, Sang Ho Choi
Abstract: Provided are a very safe skin whitening agent, melanin production inhibitor, and dopa oxidase activity inhibitor. Use of kitsunenomago or an organic solvent extract thereof to inhibit the dopa oxidase activity.
Abstract: The present invention is directed to compositions and processes for their use that allow for the delivery of physiologically active agents, using a unique composition containing glycerin and triglycerides in the proper ratio. The composition functions by acting both as a humectant and occlusive agent attracting water, returning the skin surface to a smooth state and holding water and physiologically active agents in place. The presence of both hydrophobic and hydrophilic components of the current invention solubilize the physiologically actives into the complex matrix, keeping the actives on the skin and allowing them to penetrate the skin over time, thus delivering the actives to the blood stream.
Type:
Grant
Filed:
March 23, 2015
Date of Patent:
October 18, 2016
Assignee:
DR. HOLMQUIST HEALTHCARE, LLC
Inventors:
C. Scott Danos, Bruce A. Cranner, Anne-Marie T. Karp